News | Women's Health | August 05, 2015

Florida Surgeon Helps Pioneer Innovative Approach to Treating Breast Cancer

Among first to adopt new biomarker device that improves radiation treatment

Mary Beth Tomaselli, Biozorb, breast cancer, radiation therapy, Florida, biomarker

Mary Beth Tomaselli, M.D., shows the BioZorb 3-D bioabsorbable marker, a small coil inserted into the breast by the surgeon when a breast cancer tumor is removed. The device holds six tiny clips arranged in a three-dimensional array. This 3D array remains over time, while the coil holding the clips dissolves. "This is a great innovation," said Dr. Tomaselli, which has been "very well received by radiation oncologists, and it's a benefit to the patients in getting more accurate radiation therapy and a more satisfying cosmetic result." Photo courtesy of Business Wire.

August 5, 2015 — A Coral Springs, Florida, surgeon is among the first in the state to adopt an innovative new device that improves the treatment of breast cancer.

Mary Beth Tomaselli, M.D., has helped pioneer use of the BioZorb tissue marker when performing surgery to remove the cancer and preserve the breast.

BioZorb is a small coil, inserted into the breast by the surgeon at the time of tumor removal, which holds six tiny clips arranged in a three-dimensional array. This 3-D array remains over time, while the coil holding the clips dissolves.

"When we surgically remove the cancer, we want to mark the exact area where the tumor was located,” said Tomaselli, medical director and co-founder of the Comprehensive Breast Center of Coral Springs. “We place this new marker precisely at the site of the tumor, oriented the same way the tumor was oriented. Then the radiation oncologist can focus the beam specifically where the tumor was."

Breast cancer can be treated by mastectomy (breast removal) or by lumpectomy. With lumpectomy, a small amount of tissue containing the tumor is removed. In addition to the surgery, it is important to add radiation treatment to “clean up” any microscopic cancer cells that might remain behind in the breast.

The addition of radiation allows surgeons to safely conserve the breast tissue, while decreasing the chances of cancer recurring in the same location. Prior to the development of the surgical marker, radiation treatments usually had to be directed at a larger portion of the breast tissue.

“This device allows us to target a smaller volume of tissue,” said Eduardo Fernandez, M.D., Ph.D., a radiation oncologist who treats many of Tomaselli’s patients after surgery. “It makes it easier for us to better protect women from unnecessary radiation exposure, and to use newer image-guided techniques.” Fernandez is a radiation oncologist and senior vice president for medical affairs at 21st Century Oncology.

Among the dozens of local patients who have benefited from the device is Monica Severn, 59. An Air Force veteran and certified X-ray technician, she directs the CareSpot Express Healthcare urgent care facility in Pembroke Pines.

Severn detected a small lump on her right breast last fall, which a biopsy determined was early-stage breast cancer. Her primary care doctor directed her to Tomaselli, who performed a lumpectomy in October. Fernandez oversaw the radiation therapy.

"He assured me they would be able to direct the radiation right where the cancer was," Severn recalled. "It was wonderful to have that pinpoint accuracy. I knew the radiation was important because you could have a few cancer cells left behind after the surgery. And you need that kind of accuracy so you don’t radiate healthy tissues.”

Tomaselli now uses the BioZorb device for virtually all lumpectomy surgeries. She noted that it’s especially valuable to help achieve a better cosmetic outcome when newer “oncoplastic” techniques are employed to reconstruct the tissue.

“This is a great innovation by someone who clearly thought this out from a surgical and patient standpoint,” she said. “It’s been very well received by the radiation oncologists, and it’s a benefit to the patients in getting more accurate radiation therapy and a more satisfying cosmetic result.”

For more information: www.focalrx.com

Related Content

Nine New Disease Sites Added to the NCCN Radiation Therapy Compendium
News | Radiation Therapy | April 26, 2017
April 26, 2017 — The National Comprehensive Cancer Network (NCCN) continues to build its NCCN Radiation Therapy Compe
Nebraska Enacts Cheri's Law for Breast Density Reporting
News | Breast Density | April 26, 2017
April 26, 2017 — Nebraska Gov.
Precision Medicine Poised to Change Brain Tumor Diagnostics and Treatment
News | Radiation Therapy | April 26, 2017
April 26, 2017 — A new report on the brain cancer diagnostics market projects that up to 78,000 new cases of primary
Elekta Highlights Leksell Vantage System for Stereotactic Neurosurgery at AANS 2017
News | Radiation Therapy | April 24, 2017
Elekta announced that its Leksell Vantage Stereotactic System, will be highlighted at the American Association of...
New Clinical Data on Xoft System Presented at American Brachytherapy Society Annual Meeting
News | Brachytherapy Systems, Women's Healthcare | April 20, 2017
iCAD Inc. announced that updated clinical data on the use of intraoperative radiation therapy (IORT) using the Xoft...
RaySearch and MD Anderson Collaborate on Development of RayCare
News | Oncology Information Management Systems (OIMS) | April 18, 2017
The University of Texas MD Anderson Cancer Center in Houston, Texas, will collaborate with RaySearch on the development...
New ASTRO Guideline Establishes Standard of Care for Curative Oropharyngeal Cancer Treatment With Radiotherapy
News | Radiation Therapy | April 17, 2017
April 17, 2017 — The American Society for Radiation Oncology (ASTRO) has issued a new clinical guideline for the mana
Kentucky and Iowa Enact Breast Density Reporting Legislation
News | Breast Density | April 14, 2017
Kentucky and Iowa both this week joined the ranks of states with laws requiring mammography facilities to inform...
News | Mammography Reporting Software | April 13, 2017
April 13, 2017 — IDS recently announced Women’s Imaging Associates, a premier teleradiology firm located in Birmingha
News | Focused Ultrasound Therapy | April 12, 2017
Theraclion announced results of a study evaluating the long-term assessment of breast fibroadenoma (benign tumor)...
Overlay Init